Search for high-quality Active Pharmaceutical Ingredients through our extensive portfolio
Why Choose Us
API Solutions
The Dr. Reddy’s API business is a leading manufacturer and supplier of high quality affordable Active Pharmaceutical Ingredients (API) to leading generic formulations manufacturers across the world, enabling them to accelerate access to affordable medicines for patients worldwide. We offer 250+ affordable, high-quality APIs in over 80+ countries. Backed by decades of R&D strength, the focus is on first-to-market, hard-to-make products, driven by sustainability and high standards in quality, safety, supply and productivity.
Generic Formulations
We enable access to medicines in markets where we are not directly present through our B2B Formulations model by supplying finished products to partners for distribution and commercialization. Our market-specific, customizable dossiers meet local regulatory requirements. In addition to formulation, tech transfer, and pre-formulation supplies, we continue expanding our global presence across key markets.
Strategic Alliances
Dr. Reddy’s leverages strategic in-licensing and out-licensing to expand its portfolio and bring innovative treatments to market efficiently. Through comprehensive tech transfer services, we enable faster development, local manufacturing, and regulatory success. Our expertise, collaboration, and end-to-end support make us a trusted partner in accelerating access to high-quality, affordable medicines worldwide.
Discovery & CDMO
Aurigene discovery & CDMO is a subsidiary of Dr. Reddy’s formed in 2020 by consolidating its service businesses into a customer-centric organization. Though young, we bring over two decades of experience in partnering with global pharma and biotech companies offering integrated services across key starting materials, intermediates, APIs, and finished dosage forms from lab to market.
Aurigene.ai
Aurigine (subsidiary of Dr. Reddy’s) is a leading CRDMO, leverages cutting-edge tools like Aurigine.AI, CADD, and bioinformatics to accelerate drug discovery. Our AI-driven platform integrates predictive, generative, and computational models with a validated compound database to streamline candidate identification. Innovations like Aurimine (a virtual library of 12+ billion compounds) reflect our commitment to faster, smarter development of innovative medicines.
Your Trusted Partner for High-Quality, Affordable APIs
Dr. Reddy’s API business is a leading manufacturer and supplier of high-quality quality affordable Active Pharmaceutical Ingredients (APIs) to leading generic formulations manufacturers across the world, enabling them to accelerate access to affordable medicines for patients worldwide. As a preferred partner across major markets, we lead with sustainability, first-to-market products, and an unwavering commitment to quality.
Why work with us
Years of serving patients
Active pharmaceutical Ingredients
DMFs filed globally
Billion USD Revenue
Countries presence
API manufacturing sites
As nossas capacidades
Advanced Research Capabilities
Reddy's compreende fortes equipes técnicas e multifuncionais, incluindo departamentos de P&D, Qualidade, Engenharia e Análise. Nossas equipes dedicadas de P&D estão comprometidas em desenvolver produtos complexos para atender às crescentes necessidades de API no ambiente GMP.
Regulatory Compliance
O Dr. Reddy tem uma experiência regulatória global incomparável focada em mercados internacionais. Nossa qualidade de primeira classe e conformidade líder do setor são projetadas para garantir que nossos produtos atendam aos rigorosos requisitos regulatórios em todo o mundo. Nossas APIs possuem registros regulatórios disponíveis nos principais mercados do mundo.
Manufacturing Excellence
Our API manufacturing facilities are operated following cGMP (ICH Q7) and regularly inspected by international regulatory authorities. We have eight commercial USFDA inspected production units, six in India, one in Mexico and one in the UK.
Our Journey in Motion
A nossa sustentabilidade
Eventos e Prémios
A Bold Leap for Global HIV Prevention: Lenacapavir Agreement SignedTentative Approval for Generic Lumateperone capsules
Thrilled to announce that we’ve officially signed the agreement for Lenacapavir with UNITAID, CHAI, and Wits RHI. Together, we are making Lenacapavir, a twice-yearly HIV prevention injection available...
Tentative Approval for Generic Lumateperone capsules
CDP Recognition
Reimagine a aquisição de APIs com
A Plataforma de Envolvimento do Cliente da Dr. Reddy oferece uma experiência perfeita na aquisição de APIs.
Access detailed information about our API offerings
Simplified process for placing orders and making requests.
Track order and get updates: Real-time tracking and status updates on your orders,
Get personalized support: Dedicated support for your specific needs.
